Stocktoria

Daiichi Sankyo Company, Limited 4568.T

JP · Tokyo Stock Exchange · XTKS · stock · Healthcare · website

Daiichi Sankyo Company, Limited (4568.T) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 2.74% (safety: moderate). FY2026 revenue was ¥2.12T at a 12.2% net margin.

Chart by TradingView
3/9
Piotroski F — financial health
4.45
Altman Z″ — distress risk · safe
49.4%
Dividend payout · moderate
¥2,608.50 as of 2026-06-01 · -22.5% 1y
¥2,588.50¥3,864.0052-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

Market cap USD$28.6B
P / E18.1×
Net margin12.2%
Revenue trend · last 4y · up

How it ranks in Healthcare · percentile among 46 companies

Piotroski Fstronger than 0%
Net marginstronger than 47%
Return on equitystronger than 69%
Revenue growthstronger than 80%

Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 3/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.314
Retained earnings / assets0.387
EBIT / assets0.057
Equity / liabilities0.711

FAQ

Is 4568.T financially healthy?

Daiichi Sankyo Company, Limited's Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does 4568.T pay a dividend, and is it safe?

Yes. Daiichi Sankyo Company, Limited pays a dividend yielding about 2.74% with a 49.4% payout ratio, rated “moderate” for safety.

How profitable is 4568.T?

In FY2026, Daiichi Sankyo Company, Limited had a net margin of 12.2% and a return on equity of 15.6%.

Source: company filings via Yahoo Finance · JP · as of 2026-03-31. Figures in JPY; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.